
Case Studies
>
Medical Diagnostics Company
Industry
Diagnostics
Audience
Investor
The Challenge
An early-revenue medical diagnostics business was raising angel funding for growth, with much of its value resting in its IP portfolio. The angel group had already used IPRSCORE™ for earlier portfolio analysis and insisted on a score as part of its due diligence on this new investment.
What IPRSCORE™ Revealed
Introduced to IPRSCORE™ by the angels, the company had its score completed within a week. It provided independent evidence of strong IP capable of supporting the scale-up business plan. Management also gained valuable outside feedback on the strength of the IP they had been building over the previous three years.
The Outcome
With validation for both investors and Management, the company closed a successful $5m investment round.
The Takeaway
IPRSCORE™ gave the angel group a unique benchmark for the new investment and a fresh IP lens for assessing the rest of its portfolio companies.